Izumi Nomura - Concepedia

Author

Izumi Nomura

Kanazawa University

Also Known As

Izumi NOMURA, Izumi Nomura, Nomura, Izumi

Publications

490

Citations

H-Index

Concepts

All Affiliations

Kanazawa University Takeda (Japan)Takeda (United States)Kyoto University

About

Izumi Nomura is an author at Kanazawa University specializing in medicine, pharmacology, and medicinal chemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	205
2	Natural Sciences	3	3	117
3	Engineering	2	2	169
4	Social Sciences	2	2	65
5	Biochemistry	2	2	62

Izumi Nomura

Publications

468

Citations

H-Index

Page 1

	Year	Citations
Rh(I)-Catalyzed Intramolecular Allenic Pauson−Khand Reaction: Construction of a Bicyclo[5.3.0]dec-1,7-dien-9-one Skeleton Chisato Mukai, Izumi Nomura, Kei Yamanishi, Organic Letters Chemical EngineeringCross-coupling ReactionDerivativesCatalytic AmountEngineering	2002	114
Efficient Construction of the Bicyclo[5.3.0]decenone Skeleton Based on the Rh(I)-Catalyzed Allenic Pauson−Khand Reaction Chisato Mukai, Izumi Nomura, Shinji Kitagaki The Journal of Organic Chemistry	2003	94
Total Synthesis of (±)-8α-Hydroxystreptazolone Izumi Nomura, Chisato Mukai Organic Letters Medicinal ChemistryBiosynthesisDerivativesPauson-khand Reaction2-Oxazolone-alkyne Derivatives	2002	55
Studies on the Total Synthesis of Streptazolin and Its Related Natural Products: First Total Synthesis of (±)-8α-Hydroxystreptazolone Izumi Nomura, Chisato Mukai The Journal of Organic Chemistry Bioorganic ChemistryFirst Total SynthesisOrganic ChemistryPharmaceutical ChemistryMedicinal Chemistry	2004	47
Mechanism of impairment of long-term potentiation by amyloid β is independent of NMDA receptors or voltage-dependent calcium channels in hippocampal CA1 pyramidal neurons Izumi Nomura, Nobuo Kato, Toru Kita, Neuroscience Letters Amyloid βSynaptic PlasticityNeurodegenerative DiseasesAlzheimer's DiseaseNeurophysiology	2005	39
Discovery of Clinical Candidate <i>N</i>-((1<i>S</i>)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-<i>b</i>]pyrazine-4(1<i>H</i>)-carboxamide (TAK-915): A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders Satoshi Mikami, Shinji Nakamura, Tomoko Ashizawa, Journal of Medicinal Chemistry Brain-penetrating Phosphodiesterase 2ABrain PenetrationPharmacotherapyCognitive DisordersPharmaceutical Chemistry	2017	37
Intraneuronally injected amyloid beta inhibits long-term potentiation in rat hippocampal slices Izumi Nomura, Hajime Takechi, Nobuo Kato Journal of Neurophysiology Synaptic TransmissionNeurochemical BiomarkersSynaptic SignalingSocial SciencesAlzheimer's Disease	2012	26
Immunogenecity of synthetic peptides representing linear B-cell epitopes of VapA of Rhodococcus equi Saı̈d Taouji, Izumi Nomura, Steeve Giguère, Vaccine Linear B-cell EpitopesPathogenesisImmunologySynthetic PeptidesAntigen Processing	2003	22
Design, synthesis, and pharmacological evaluation of 4-azolyl-benzamide derivatives as novel GPR52 agonists Kazuyuki Tokumaru, Y. ITO, Izumi Nomura, Bioorganic & Medicinal Chemistry Combinatorial ChemistryMedicineDrug Discovery4-Azolyl-benzamide DerivativesPharmacological Agent	2017	19
Discovery of a Novel Series of Pyrazolo[1,5-<i>a</i>]pyrimidine-Based Phosphodiesterase 2A Inhibitors Structurally Different from <i>N</i>-((1<i>S</i>)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-<i>b</i>]pyrazine-4(1<i>H</i>)-carboxamide (TAK-915), for the Treatment of Cognitive Disorders Satoshi Mikami, Masanori Kawasaki, Shuhei Ikeda, Chemical and Pharmaceutical Bulletin Lead CompoundsPharmacotherapyCognitive DisordersNew SeriesChemical Biology	2017	15

Page 1